New blood test could replace biopsies in predicting heart transplant rejection
from By Karen Zabel
For years, tissue biopsy has been regarded as the gold standard for predicting the potential for heart transplant rejection, but now researchers from Stanford say they've developed a blood test that is able to predict rejection weeks or even months earlier than that technique. The Stanford researchers also indicate the new test outperforms another rejection prediction blood test called Allomap "by a substantial margin."
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063